Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HPF2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.721 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.451 |
CLV_PCSK_PC1ET2_1 | 156 | 158 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.527 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.768 |
DOC_CKS1_1 | 150 | 155 | PF01111 | 0.464 |
DOC_CKS1_1 | 34 | 39 | PF01111 | 0.615 |
DOC_MAPK_gen_1 | 156 | 164 | PF00069 | 0.473 |
DOC_MAPK_gen_1 | 178 | 186 | PF00069 | 0.464 |
DOC_MAPK_MEF2A_6 | 178 | 186 | PF00069 | 0.512 |
DOC_MAPK_MEF2A_6 | 224 | 232 | PF00069 | 0.283 |
DOC_PP1_RVXF_1 | 39 | 46 | PF00149 | 0.507 |
DOC_PP1_RVXF_1 | 97 | 103 | PF00149 | 0.520 |
DOC_PP2B_LxvP_1 | 182 | 185 | PF13499 | 0.475 |
DOC_PP4_FxxP_1 | 250 | 253 | PF00568 | 0.490 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.617 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.680 |
DOC_USP7_MATH_1 | 238 | 242 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.614 |
DOC_WW_Pin1_4 | 149 | 154 | PF00397 | 0.470 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.553 |
LIG_14-3-3_CanoR_1 | 92 | 100 | PF00244 | 0.493 |
LIG_APCC_ABBA_1 | 202 | 207 | PF00400 | 0.452 |
LIG_BRCT_BRCA1_1 | 166 | 170 | PF00533 | 0.538 |
LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.259 |
LIG_BRCT_BRCA1_1 | 41 | 45 | PF00533 | 0.432 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.513 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.384 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.405 |
LIG_LIR_Gen_1 | 159 | 169 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 155 | 161 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.498 |
LIG_LYPXL_SIV_4 | 70 | 78 | PF13949 | 0.474 |
LIG_PTB_Apo_2 | 113 | 120 | PF02174 | 0.555 |
LIG_REV1ctd_RIR_1 | 86 | 96 | PF16727 | 0.496 |
LIG_SH2_CRK | 71 | 75 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.584 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.408 |
LIG_SH3_2 | 151 | 156 | PF14604 | 0.611 |
LIG_SH3_3 | 135 | 141 | PF00018 | 0.683 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.583 |
LIG_SH3_3 | 21 | 27 | PF00018 | 0.544 |
LIG_SH3_3 | 250 | 256 | PF00018 | 0.343 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.554 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.495 |
LIG_TRAF2_1 | 109 | 112 | PF00917 | 0.348 |
LIG_TYR_ITIM | 69 | 74 | PF00017 | 0.525 |
LIG_UBA3_1 | 1 | 9 | PF00899 | 0.768 |
MOD_CDK_SPK_2 | 33 | 38 | PF00069 | 0.376 |
MOD_CDK_SPxxK_3 | 149 | 156 | PF00069 | 0.459 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.525 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.562 |
MOD_CK1_1 | 39 | 45 | PF00069 | 0.455 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.459 |
MOD_GlcNHglycan | 128 | 132 | PF01048 | 0.422 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.561 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.397 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.506 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.699 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.389 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.777 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.611 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.691 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.557 |
MOD_N-GLC_1 | 238 | 243 | PF02516 | 0.578 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.566 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.562 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.501 |
MOD_NEK2_2 | 52 | 57 | PF00069 | 0.561 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.614 |
MOD_Plk_1 | 238 | 244 | PF00069 | 0.632 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.692 |
MOD_Plk_4 | 139 | 145 | PF00069 | 0.596 |
MOD_Plk_4 | 189 | 195 | PF00069 | 0.461 |
MOD_ProDKin_1 | 149 | 155 | PF00069 | 0.463 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.546 |
TRG_DiLeu_BaEn_2 | 17 | 23 | PF01217 | 0.521 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 210 | 213 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.434 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCH2 | Leptomonas seymouri | 67% | 100% |
A0A0S4IV73 | Bodo saltans | 36% | 100% |
A0A1X0NKA4 | Trypanosomatidae | 45% | 100% |
A0A3S7XB21 | Leishmania donovani | 79% | 100% |
A4ICJ3 | Leishmania infantum | 79% | 100% |
D0A3G4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AT63 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
Q4Q1D4 | Leishmania major | 76% | 99% |